Discussion
The median life span of a silicone breast implant is said to be approximately 16.4 years, with 48.7% still intact by this stage. This does not, however, accurately reflect the number of undetected or "silent" ruptures, as in this case (1) . Rupture of a silicone breast implant can be either intracapsular or extracapsular. The latter, while less common, can extravasate into surrounding breast tissue, lung parenchyma, chest-wall muscles, and lymph nodes in the axilla and supraclavicular fossa (2-6). Subcutaneous siliconomas have also been reported in more distal areas such as the abdominal wall, inguinal region, and lower limbs (7, 8) . There is one published case report of the internal mammary chain as a site of silicone migration and foreign-body granulomatous formation (9) .
A study by Chen et al. (10) found breast cancer recurrence in the ipsilateral internal mammary lymph nodes in 1.5% of patients who previously underwent mastectomy. It is important to note that these nodes are rarely excised during breast cancer surgery and, as all quadrants of the breast have lymphatic drainage to this area, tumors from any part of the breast can potentially metastasize there (10-13). The internal mammary node chain is therefore a region that must be carefully monitored on followup imaging for breast cancer.
In this case, local lymphadenopathy due to siliconoma is the point of interest. Leaking silicone from ruptured implants may accumulate in draining lymph nodes all across the body. An enlarged internal mammary lymph node in the context of metachronous bilateral breast cancer poses a challenging situation and potential diagnostic pitfall if a siliconoma is misinterpreted as a malignant lymph node.
Selective, silicone-sensitive MRI sequences may help solve this dilemma in a noninvasive fashion. However, if in doubt, a CT-guided or US-guided biopsy may produce an unequivocal diagnosis and thus help allay a patient's fears and apprehension.
